BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29046905)

  • 1. The controversial role of forkhead box F2 (FOXF2) transcription factor in breast cancer.
    Lo PK
    PRAS Open; 2017; 1():. PubMed ID: 29046905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells.
    Lo PK
    Trends Diabetes Metab; 2018; 1(1):. PubMed ID: 30294731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.
    Tian HP; Lun SM; Huang HJ; He R; Kong PZ; Wang QS; Li XQ; Feng YM
    J Biol Chem; 2015 Jul; 290(31):19173-83. PubMed ID: 26070560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
    Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
    FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
    Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
    J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-β and miR-182-5p.
    Lu JT; Tan CC; Wu XR; He R; Zhang X; Wang QS; Li XQ; Zhang R; Feng YM
    Cell Death Differ; 2020 Oct; 27(10):2973-2987. PubMed ID: 32424142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.
    Yu ZH; Lun SM; He R; Tian HP; Huang HJ; Wang QS; Li XQ; Feng YM
    Cancer Lett; 2017 Aug; 402():142-152. PubMed ID: 28577976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory roles and mechanisms of the transcription factor FOXF2 in human diseases.
    Wu Q; Li W; You C
    PeerJ; 2021; 9():e10845. PubMed ID: 33717680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21
    Milewski D; Pradhan A; Wang X; Cai Y; Le T; Turpin B; Kalinichenko VV; Kalin TV
    Oncogene; 2017 Feb; 36(6):850-862. PubMed ID: 27425595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Shh-Foxf-Fgf18-Shh Molecular Circuit Regulating Palate Development.
    Xu J; Liu H; Lan Y; Aronow BJ; Kalinichenko VV; Jiang R
    PLoS Genet; 2016 Jan; 12(1):e1005769. PubMed ID: 26745863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.
    Zhang X; Ma G; Liu J; Zhang Y
    Oncol Lett; 2017 Oct; 14(4):4805-4811. PubMed ID: 29085483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXF2 acts as a crucial molecule in tumours and embryonic development.
    He W; Kang Y; Zhu W; Zhou B; Jiang X; Ren C; Guo W
    Cell Death Dis; 2020 Jun; 11(6):424. PubMed ID: 32503970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
    Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
    Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXF2 deficiency permits basal-like breast cancer cells to form lymphangiogenic mimicry by enhancing the response of VEGF-C/VEGFR3 signaling pathway.
    Wang QS; He R; Yang F; Kang LJ; Li XQ; Fu L; Sun B; Feng YM
    Cancer Lett; 2018 Apr; 420():116-126. PubMed ID: 29409810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroparesis is associated with decreased FOXF1 and FOXF2 in humans, and loss of FOXF1 and FOXF2 results in gastroparesis in mice.
    Herring BP; Hoggatt AM; Gupta A; Wo JM
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13528. PubMed ID: 30565344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.